-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ti6uyFd1Fwz3kDvHQKSf4RmgTz+pXSclpUsioEQaJDUCJcRUNefDjMANCNWLm/MX IUtE4eVGuKcOb0c4gSoJ3w== 0000893838-99-000031.txt : 19990217 0000893838-99-000031.hdr.sgml : 19990217 ACCESSION NUMBER: 0000893838-99-000031 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AUTOIMMUNE INC CENTRAL INDEX KEY: 0000879106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133489062 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-44757 FILM NUMBER: 99539106 BUSINESS ADDRESS: STREET 1: 128 SPRING ST CITY: LEXINGTON STATE: MA ZIP: 02173 BUSINESS PHONE: 6178600710 MAIL ADDRESS: STREET 1: 128 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02173 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FOUR PARTNERS CENTRAL INDEX KEY: 0000942714 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O B.L. BLOOM STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-545-2930 SC 13G/A 1 AMENDMENT NO.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* AutoImmune Inc. - ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.01 par value - ------------------------------------------------------------------------------- (Title of Class of Securities) 05277610 - ------------------------------------------------------------------------------- (CUSIP Number) - ------------------------------------------------------------------------------- December 31, 1998 - ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 05277610 13G - ------------ ------------------------------------------------------------------ 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Four Partners - ------------ ------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - ------------ ------------------------------------------------------------------ 3 SEC USE ONLY - ------------ ------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - --------------------------------- ---------- ---------------------------------- 5 SOLE VOTING POWER 2,022,000 NUMBER OF ---------- ---------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- ---------- ---------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 2,022,000 ---------- ---------------------------------- WITH 8 SHARED DISPOSITIVE POWER -0- - ------------ ------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,022,000 - ------------ ------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - ------------ ------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - ------------ ------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* PN - ------------ ------------------------------------------------------------------ 2 Item 1. (a) Name of Issuer AutoImmune Inc. (the "Issuer") (b) Address of Issuer's Principal Executive Offices 128 Spring Street Lexington, Massachusetts 02173 Item 2. (a) Name of Persons Filing Four Partners ("FP") (b) Address of Principal Business Office or, if none, Residence Four Partners c/o Thomas J. Tisch 667 Madison Avenue New York, NY 10021 (c) Citizenship New York (d) Title of Class of Securities Common Stock, $0.01 par value (the "Shares") (e) CUSIP Number 05277610 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) |_| Broker or Dealer registered under Section 15 of the Act, (b) |_| Bank as defined in section 3(a)(6) of the Act, (c) |_| Insurance company as defined in section 3(a)(19) of the Act, (d) |_| Investment company registered under section 8 of the Investment Company Act of 1940, (e) |_| Investment Adviser registered under section 203 of the Investment Advisers Act of 1940, (f) |_| An employee benefit plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see (section) 240.13d-1(b)(1)(ii)(F), (g) |_| A parent holding company, in accordance with (section) 240.13d-1(b)(ii)(G) (Note: See Item 7), (h) |_| A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); 3 (j) |_| Group, in accordance with (section) 240.13d-1(b)(1) (ii)(J). If this statement is filed pursuant to (section) 240.13d-1(c), check this box |X|. Item 4. Ownership (a) Amount Beneficially Owned As of the date hereof, FP is the beneficial owner of 2,022,000 Shares. (b) Percent of Class FP is the record owner of 12.2% of the outstanding Shares. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote FP has directly the sole power to vote or direct the vote of the 2,022,000 Shares owned by it. (ii) Shared power to vote or to direct the vote By virtue of their status as managing trustees of the trusts which are the general partners of FP, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch and Thomas J. Tisch (the "Messrs. Tisch") may be deemed to have indirectly shared power to vote or direct the vote of the 2,022,000 Shares owned by FP. (iii) Sole power to dispose or to direct the disposition of FP has directly the sole power to dispose or direct the disposition of the 2,022,000 Shares owned by it. (iv) Shared power to dispose or to direct the disposition of By virtue of their status as managing trustees of the trusts which are the general partners of FP, the Messrs. Tisch may be deemed to have indirectly shared power to dispose or direct the disposition of the 2,022,000 Shares owned by FP. Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group 4 Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 12, 1999 FOUR PARTNERS By: /s/ Thomas J. Tisch ------------------------------------ Thomas J. Tisch Manager of Four Partners 5 -----END PRIVACY-ENHANCED MESSAGE-----